| Drug Name |
Lymecycline |
| Drug ID |
BADD_D01333 |
| Description |
Lymecycline is a broad-spectrum second-generation tetracycline antibiotic used for the treatment of acne and other susceptible bacterial infections.[L13880,L13883] It has been proven a cost-effective alternative to treatment with [minocycline] with comparable safety and efficacy.[A203255] Lymecycline was initially discovered in 1961. It is marketed by Galderma and used in the UK as well as New Zealand in addition to other countries. Lymecycline is not marketed in the USA, however, equivalent drugs are available, such as minocycline and [tetracycline].[A19429,L13880] |
| Indications and Usage |
For the treatment of infections and to treat acne. It may also be used to treat urinary tract infections, gum disease, and other bacterial infections such as gonorrhea and chlamydia. Lymecycline is also used commonly as a prophylactic treatment for infection by Bacillus anthracis (anthrax). It is also effective against Yersinia pestis and malaria and is also prescribed for the treatment of Lyme disease. |
| Marketing Status |
Not Available |
| ATC Code |
J01AA04 |
| DrugBank ID |
DB00256
|
| KEGG ID |
D06884
|
| MeSH ID |
D008194
|
| PubChem ID |
54707177
|
| TTD Drug ID |
D04VEJ
|
| NDC Product Code |
Not Available |
| Synonyms |
Lymecycline | N-Lysinomethyltetracycline | N Lysinomethyltetracycline | Tetracyclinemethylene Lysine | Lysine, Tetracyclinemethylene | Tetracycline-L-Methylene Lysine | Lysine, Tetracycline-L-Methylene | Tetracycline L Methylene Lysine | Lymecycline Hydrochloride | Hydrochloride, Lymecycline |
